Opsoclonus-Myoclonus Syndrome in a Child with Birth Asphyxia
Main Article Content
Abstract
A case of Opsoclonus Myoclonus Syndrome associated with birth asphyxia presented with antiseizure treatment started soon after birth and continued after discharge. The child presented at two years of age and had jerky movements in the limbs and eyes. The eye movements promptly responded to phenobarbital, and the limb movements appreciably diminished after adding clonazepam. The practice of continuing antiseizure treatment post-discharge in asphyxiated babies is questionable. No asphyxiated baby is reported in the literature to have OMS.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Bhatia P, Heim J, Cornejo P, Kane L, Santiago J, Cruer M. Opsoclonus–myoclonus–ataxia syndrome in children. Journal of Neurology 2022; 269:750–757.
3. Krug P, Schleiermacher G, Hichon J, Valteau-Counet D, Brisse H. Opsoclonus-myoclonus in children associated or not with neuroblastoma. European Journal of Paediatric Neurology 2010;14: 400-409.
4. Sewell EK, Shankaran S, McDonald SA, et al. Antiseizure medication at discharge in infants with hypoxic-ischaemic encephalopathy: an observational study. Arch Dis Child Fetal Neonatal Ed 2023; 108:421–8.
5. Hunt RW. Neonatal seizures. Treat! But when, with what, and for how long? Arch Dis Child Fetal Neonatal Ed 2023;108: F552– F553.
6. Glass HC, Soul JS, Chang T, et al. Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures. JAMA Neurol 2021; 78:817–25.